Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price traded down 11.8% during trading on Thursday . The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The business’s 50-day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23. The stock has a market cap of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- How to Invest in Insurance Companies: A Guide
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 3 Stocks to Consider Buying in October
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
